FDA nixes fast track for cancer vaccine
(AP)
<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/ap/20070531/ap_on_he_me/britain_glaxosmithkline"><img src="http://d.yimg.com/us.yimg.com/p/rids/20070524/i/r3634665236.jpg?x=130&y=88&sig=OVP60lOrGdaxSzjfGUtkvg--" align="left" height="88" width="130" alt="A scientist works in GlaxoSmithKline's plant in Singapore in a file photo. GlaxoSmithKline is expected to be hit with a wave of lawsuits from users of the diabetes drug Avandia, plaintiff's lawyers said on Wednesday. REUTERS/Luis Enrique Ascui" border="0" /></a>AP - GlaxoSmithKline PLC revealed Thursday that the U.S. Food and Drug Administration has declined to grant a priority review to its experimental cancer vaccine Cervarix, adding to pressure on the drug maker after controversy surrounding its diabetes drug Avandia.</p><br clear="all"/>

Read more...